Nordion (Canada) Inc.

Nordion (Canada) Inc. (Nordion) owns and is licensed to operate a nuclear substance processing facility, located in Ottawa, Ontario. The CNSC has full-time, dedicated staff who periodically perform inspections to evaluate operations and to verify compliance with regulatory requirements and licence conditions.

Facility Information

Nordion (Canada) Inc.

Nordion (Canada) Inc.

Location: Ottawa, Ontario
Licensee: Nordion (Canada) Inc.
Status: Operating
Licence issued: November 1, 2015
Licence expires: October 31, 2025
Start of commercial operation: 1946
Licensing documentation: Request a copy of Nordion's nuclear substance processing facility licence by email

Nordion is a health science company that processes nuclear substances (radioisotopes) for medical and industrial applications. For more information, visit Nordion's website.

Operating Performance of Nordion

The CNSC produces an annual report on the performance of uranium fuel cycle and processing facilities, which includes Nordion. The report provides information on events, facility modifications, and areas of increased regulatory focus. It also tracks data on:

  • public and worker radiation dose
  • lost-time incidents for workers
  • environmental monitoring results
  • environmental reportable spills and corrective actions taken
  • current financial guarantees for future decommissioning costs

Read the report to learn about Nordion's operating performance.

Latest CNSC Facility-Specific Announcements


Radioisotopes are used for the diagnostic of diseases such as cancer, heart disease and bone ailments

Disclosure Protocol

As part of CNSC's regulatory requirements, major licensees must have robust public information and disclosure programs in place.

Regulatory Reporting

Other Key Topics